Your browser doesn't support javascript.
loading
Safety, pharmacokinetics, and pharmacodynamics of S-(-)-pantoprazole sodium injections after single and multiple intravenous doses in healthy Chinese subjects.
Jiao, Hui-Wen; Sun, Lu-Ning; Li, Yue-Qi; Yu, Lei; Zhang, Hong-Wen; Wang, Mei-Feng; Yu, Li-Yuan; Yuan, Zi-Qing-Yun; Xie, Li-Jun; Chen, Juan; Meng, Ling; Zhang, Xue-Hui; Wang, Yong-Qing.
Affiliation
  • Jiao HW; Research Division of Clinical Pharmacology, The First Affiliated Hospital with Nanjing Medical University, 300 Guangzhou Road, Nanjing, 210029, People's Republic of China.
  • Sun LN; Research Division of Clinical Pharmacology, The First Affiliated Hospital with Nanjing Medical University, 300 Guangzhou Road, Nanjing, 210029, People's Republic of China.
  • Li YQ; Research Division of Clinical Pharmacology, The First Affiliated Hospital with Nanjing Medical University, 300 Guangzhou Road, Nanjing, 210029, People's Republic of China.
  • Yu L; Research Division of Clinical Pharmacology, The First Affiliated Hospital with Nanjing Medical University, 300 Guangzhou Road, Nanjing, 210029, People's Republic of China.
  • Zhang HW; Research Division of Clinical Pharmacology, The First Affiliated Hospital with Nanjing Medical University, 300 Guangzhou Road, Nanjing, 210029, People's Republic of China.
  • Wang MF; Research Division of Clinical Pharmacology, The First Affiliated Hospital with Nanjing Medical University, 300 Guangzhou Road, Nanjing, 210029, People's Republic of China.
  • Yu LY; Research Division of Clinical Pharmacology, The First Affiliated Hospital with Nanjing Medical University, 300 Guangzhou Road, Nanjing, 210029, People's Republic of China.
  • Yuan ZQ; Research Division of Clinical Pharmacology, The First Affiliated Hospital with Nanjing Medical University, 300 Guangzhou Road, Nanjing, 210029, People's Republic of China.
  • Xie LJ; Research Division of Clinical Pharmacology, The First Affiliated Hospital with Nanjing Medical University, 300 Guangzhou Road, Nanjing, 210029, People's Republic of China.
  • Chen J; Research Division of Clinical Pharmacology, The First Affiliated Hospital with Nanjing Medical University, 300 Guangzhou Road, Nanjing, 210029, People's Republic of China.
  • Meng L; Research Division of Clinical Pharmacology, The First Affiliated Hospital with Nanjing Medical University, 300 Guangzhou Road, Nanjing, 210029, People's Republic of China.
  • Zhang XH; Department of Pharmacy, Jiangsu Shengze Hospital, Suzhou, 215228, People's Republic of China.
  • Wang YQ; Research Division of Clinical Pharmacology, The First Affiliated Hospital with Nanjing Medical University, 300 Guangzhou Road, Nanjing, 210029, People's Republic of China. wyqjsph@163.com.
Eur J Clin Pharmacol ; 74(3): 257-265, 2018 Mar.
Article in En | MEDLINE | ID: mdl-29167917
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: 2-Pyridinylmethylsulfinylbenzimidazoles / Proton Pump Inhibitors / Gastric Acid / Gastric Mucosa / Anti-Ulcer Agents Type of study: Prognostic_studies Limits: Adult / Female / Humans / Male Country/Region as subject: Asia Language: En Journal: Eur J Clin Pharmacol Year: 2018 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: 2-Pyridinylmethylsulfinylbenzimidazoles / Proton Pump Inhibitors / Gastric Acid / Gastric Mucosa / Anti-Ulcer Agents Type of study: Prognostic_studies Limits: Adult / Female / Humans / Male Country/Region as subject: Asia Language: En Journal: Eur J Clin Pharmacol Year: 2018 Document type: Article Country of publication: